About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
National Taiwan University Hospital
›
Department of Oncology
›
Top Articles
Department of Oncology
National Taiwan University Hospital
1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index
Most Cited Articles of Department of Oncology in 2012
Title
Journal
Year
Citations
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
Blood
2012
180
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
Blood
2012
101
Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α
Gastroenterology
2012
85
Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK
Nature
2012
80
Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT
Radiotherapy and Oncology
2012
77
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR
Journal of Thoracic Oncology
2012
76
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study
Journal of Hepatology
2012
75
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment
Translational Cancer Research
2012
71
Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer
PLoS ONE
2012
50
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
Oral Oncology
2012
49
Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma
Molecular Medicine
2012
48
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor
Neoplasia
2012
46
Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis
Oral Oncology
2012
45
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
Biochemical Pharmacology
2012
42
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
Journal of Magnetic Resonance Imaging
2012
42
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis
Oncogene
2012
41
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
International Journal of Cancer
2012
37
Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy
Clinical Cancer Research
2012
37
Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: a meta-analysis
Cancer Treatment Reviews
2012
36
SOX4 transcriptionally regulates multiple SEMA3/plexin family members and promotes tumor growth in pancreatic cancer
PLoS ONE
2012
36
The impact of diabetes mellitus on prognosis of early breast cancer in Asia
Oncologist
2012
35
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
Biochemical Pharmacology
2012
34
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study
Cancer
2012
34
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer
Oral Diseases
2012
30
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells
PLoS ONE
2012
30
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.